About Centrillion Technologies
Centrillion Technologies is a Healthcare company based in Palo Alto (United States) founded in 2009. Centrillion Technologies has raised $94.6 million across 9 funding rounds from investors including HHS and WeDoctor. The company has 23 employees. Centrillion Technologies offers products and services including VirusHunter Assays, Spatial Transcriptomics, Genotyping Services, ATOM Chips, and QuadCore DNA Sequencing. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Genomics. Its legal entity is CENTRILLION TECHNOLOGIES, INC. Its competitors include Rejuvenate Bio, Genewiz and 20n; 2 of its 3 listed competitors have raised funding.
Company details
Developer of DNA chips and molecular assays. The company focused on developing sequencing and bioinformatics solutions for genomic analysis for applications in drug discovery and life sciences research. The platform is leveraging engineering and biochemistry knowledge to accelerate discovery and understand the genomes complexity. The solutions are targeted for sequencing, chromosome-scale sequencing, genotyping, and 3D gene expression.
- Headquarters Palo Alto, United States
- Employees 23
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website centrilliontech.com
- Social LinkedIn X
- Legal Name Centrillion Technologies, Inc.
- Total Equity Funding$94.6M (USD)
in 9 rounds
- Latest Funding Round$55.6M (USD), Series C
Jul 2018
- InvestorsHHS
& 1 more
- Employee Count23
Products & Services of Centrillion Technologies
Centrillion Technologies offers a comprehensive portfolio of products and services, including VirusHunter Assays, Spatial Transcriptomics, Genotyping Services, ATOM Chips, and QuadCore DNA Sequencing.
Assays for fast SARS-CoV-2 detection and sequencing.
Technology for quantitative RNA detection with spatial resolution.
Ligation-based assays for high-quality human genotyping results.
Chips for high-throughput detection of up to 384 samples.
Chips for accurate SARS-CoV-2 genome sequencing and variant tracking.
Funding Insights of Centrillion Technologies
Centrillion Technologies has successfully raised a total of $94.6M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $55.6 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $94.6M
- Total Rounds 9
- Last Round Series C — $55.6M
- First Round $5.8M
(Oct 2009)
- Investors Count 2
All 9 funding rounds of Centrillion Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Centrillion Technologies
Centrillion Technologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and WeDoctor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Online platform to find healthcare professionals | 2010 | wedoctor.com | Hangzhou, China | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Centrillion Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Centrillion Technologies
3 dated milestones of Centrillion Technologies across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Centrillion Technologies is founded.
- Funding First funding round of $5.8M.
- Funding Latest funding round, Series C, of $55.6M.
Competitors of Centrillion Technologies
Centrillion Technologies has 3 listed competitors in our database, 2 of them funded. They include Rejuvenate Bio, Genewiz and 20n.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. | ||
| 20n.com | 2013 | San Francisco, United States | $2.22M | Computational tools are developed to engineer microbes for synthetic biology. |
Detailed competitors of Centrillion Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Centrillion Technologies
The website of Centrillion Technologies (centrilliontech.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 37.4% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Centrillion Technologies (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Centrillion Technologies
Complete news archive for Centrillion Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centrillion Technologies
Centrillion Technologies was founded in 2009.
Centrillion Technologies is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Centrillion Technologies is a funded company, having raised a total of $94.6M across 9 funding rounds to date. The company's 1st funding round was a Series A of $5.8M, raised on Oct 2009.
Centrillion Technologies has 23 employees.
Developer of DNA chips and molecular assays. The company focused on developing sequencing and bioinformatics solutions for genomic analysis for applications in drug discovery and life sciences research. The platform is leveraging engineering and biochemistry knowledge to accelerate discovery and understand the genomes complexity. The solutions are targeted for sequencing, chromosome-scale sequencing, genotyping, and 3D gene expression.
Centrillion Technologies's top competitors include Genewiz, Rejuvenate Bio and 20n.
Centrillion Technologies offers VirusHunter Assays, Spatial Transcriptomics, Genotyping Services, ATOM Chips, and QuadCore DNA Sequencing.
Centrillion Technologies operates through Centrillion Technologies, Inc..